Jadenu 360 MG Oral Tablet

RxCUI
1607794
RxNorm name
Jadenu 360 MG Oral Tablet
Display name
Jadenu 360 MG Oral Tablet
Full name
Jadenu 360 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JadenuDEFERASIROXNovartis Pharmaceuticals Corporationfee89140-fff1-4443-9f42-24ac004fcda12025-12-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1607794

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fee89140-fff1-4443-9f42-24ac004fcda1Jadenu 360 MG Oral TabletSY26These highlights do not include all the information needed to use JADENU safely and effectively. See full prescribing information for JADENU. JADENU ® (deferasirox) tablets, for oral use JADENU ® Sprinkle (deferasirox) granules, for oral use Initial U.S. Approval: 200520251211
fee89140-fff1-4443-9f42-24ac004fcda1Jadenu 360 MG Oral TabletPSN26These highlights do not include all the information needed to use JADENU safely and effectively. See full prescribing information for JADENU. JADENU ® (deferasirox) tablets, for oral use JADENU ® Sprinkle (deferasirox) granules, for oral use Initial U.S. Approval: 200520251211
fee89140-fff1-4443-9f42-24ac004fcda1deferasirox 360 MG Oral Tablet [Jadenu]SBD26These highlights do not include all the information needed to use JADENU safely and effectively. See full prescribing information for JADENU. JADENU ® (deferasirox) tablets, for oral use JADENU ® Sprinkle (deferasirox) granules, for oral use Initial U.S. Approval: 200520251211